Where does Cala Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cala Health, Inc. ranks #10,883 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cala Health, Inc. hold?

Cala Health, Inc. holds 28 US utility patents granted between 2016 and 2025, spanning 3 technology areas.

What is Cala Health, Inc.'s Innovation Score?

Cala Health, Inc. has an Innovation Score of 36.2 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cala Health, Inc. focus on?

Cala Health, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 28 patents, ranking #139 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Cala Health, Inc.'s patent grant rate increasing or decreasing?

Cala Health, Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cala Health, Inc.'s patents?

Cala Health, Inc.'s patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cala Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cala Health, Inc.

USPTO PatentsView assignee record - 28 granted patents across 3 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cala ranks #10,883 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 3 technology areas.

#10,883
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.2/100): 19.6
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10883 · US Corporation #10,883 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,883/49,997
PHOTO-FINISH Caldwell Manufacturi…
CPC-NARROW A61N · 3 areas
INNOV-THIN 36.2/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Caldwell Manufacturing Company North America, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cala’s 36.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (32%) Velocity 6.7 pts (19%) Breadth 6.1 pts (17%) Claim depth 11.8 pts (33%)

Qualcomm Incorporated · highest

85
ADC Telecommunicatio… · near

36
Cala Health · this assignee

36
Guangdong Sirui… · near

36
Interactive… · near

36
Optimedica · near

36
3D Lighting… · lowest

7

What this shows Cala's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cala?

Each dot is one of Cala’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cala’s own 19.6 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cala vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cala's grants concentrate

Cala Health, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2016. By volume, Cala sits between Crocus Technology Inc. and Cianna Medical, Inc..

Cala's three-year grant acceleration

Cala Health, Inc. shows 11 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Crocus Technology

28
Crucialtec

28
CUE Health

28
Cyberdyne

28
Caldwell Manufact…

28
Carlsberg Breweri…

28
Cerebri AI

28
Cianna Medical

28
Cala Health ◀

28

What this shows Cala holds 28 patents at rank #10,895, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cala

By rank, the assignees closest to #10,895 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cala's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cala, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Cala ranks #139 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Interactive Intelligence Group, Inc. 36 Guangdong Sirui Optical Co., Ltd. 36 Optimedica Corporation 36 ADC Telecommunications (SHANGHAI) Distribution Co., Ltd. 36

Cala's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cala Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	3.6%
2017	1	3.6%
2019	2	7.1%
2020	7	25.0%
2021	2	7.1%
2022	2	7.1%
2023	2	7.1%
2024	7	25.0%
2025partial year	4	14.3%

Which technologies does Cala Health, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 28

A61B - DIAGNOSIS; SURGERY; Identification 17

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cala Health, Inc.'s patent record in context - here's where to go next.

Cala Health, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #10,883 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cala Health, Inc. against Crocus Technology Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.